SPDR S&P Biotech ETF
274 hedge funds and large institutions have $2.17B invested in SPDR S&P Biotech ETF in 2016 Q4 according to their latest regulatory filings, with 83 funds opening new positions, 75 increasing their positions, 72 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
28% less call options, than puts
Call options by funds: $793M | Put options by funds: $1.1B
29.78% less ownership
Funds ownership: 118.69% → 88.91% (-30%)
30% less capital invested
Capital invested by funds: $3.11B → $2.17B (-$946M)
Holders
274
Holding in Top 10
6
Calls
$793M
Puts
$1.1B
Top Buyers
| 1 | +$72.4M | |
| 2 | +$32.5M | |
| 3 | +$29.9M | |
| 4 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
+$29.7M |
| 5 |
OTPPB
Ontario Teachers' Pension Plan Board
Toronto,
Ontario, Canada
|
+$26M |
Top Sellers
| 1 | -$264M | |
| 2 | -$247M | |
| 3 | -$99.4M | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$91.4M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$89.1M |